Translational Development Acquisition Corp. financial data

Symbol
TDAC, TDACU, TDACW on Nasdaq
Location
52 E 83 Rd St., New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 105 %
Debt-to-equity -105 %
Return On Equity -79 %
Return On Assets 2.68 %

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 0 shares
Entity Public Float 0 USD

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 214K USD +249%
Operating Income (Loss) -916K USD -249%
Nonoperating Income (Expense) 1.87M USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 4.76M USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.2K USD
Assets, Current 80.6K USD
Assets 180M USD
Accounts Payable, Current 16.2K USD +1193%
Liabilities, Current 423K USD
Liabilities 6.46M USD
Retained Earnings (Accumulated Deficit) -6.38M USD
Stockholders' Equity Attributable to Parent -6.38M USD -1018%
Liabilities and Equity 180M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -232K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 47.2K USD -79%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares